- Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer
- Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
- Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production
- Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
- CRISPR/Cas9: A powerful tool for identification of new targets for cancer treatment
- Correction: I Just Ran a Thousand Analyses: Benefits of Multiple Testing in Understanding Equivocal Evidence on Gene-Environment Interactions
- Phase analysis of gated PET in the evaluation of mechanical ventricular synchrony: A narrative overview
- Squamous cell carcinoma antigen concentration in fine needle aspiration samples: A new method to detect cervical lymph node metastases of head and neck squamous cell carcinoma
- Correspondence between primary and secondary care about patients with cancer: a Delphi consensus study
- Design, optimization, and multisite evaluation of a targeted next-generation sequencing assay system for RNA fusions and exon-skipping events in non-small cell lung cancer.
Most Used Journals
Bio-inspired pulmonary surfactant-modified nanogels: a promising siRNA delivery system.
J Control Release. 2015 Mar 16;
Authors: De Backer L, Braeckmans K, Stuart MC, Demeester J, De Smedt SC, Raemdonck K
Inhalation therapy with small interfering RNA (siRNA) is a promising approach in the treatment of pulmonary disorders. However, clinical translation is severely limited by the lack of suitable delivery platforms. In this study, we aim to address this limitation by designing a novel bioinspired hybrid nanoparticle with a core-shell nanoarchitecture, consisting of a siRNA-loaded dextran nanogel (siNG) core and a pulmonary surfactant (Curosurf®) outer shell. The decoration of siNGs with a surfactant shell enhances the colloidal stability and prevents siRNA release in the presence of competing polyanions, which are abundantly present in biofluids. Additionally, the impact of the surfactant shell on the biological efficacy of the siNGs is determined in lung cancer cells. The presence of the surfactants substantially reduces the cellular uptake of siNGs. Remarkably, the lowered intracellular dose does not impede the gene silencing effect, suggesting a crucial role of the pulmonary surfactant in the intracellular processing of the nanoparticles. In order to surmount the observed reduction in cellular dose, folate is incorporated as a targeting ligand in the pulmonary surfactant shell to incite receptor-mediated endocytosis. The latter substantially enhances both cellular uptake and gene silencing potential, achieving efficient knockdown at siRNA concentrations in the low nanomolar range.
PMID: 25791835 [PubMed – as supplied by publisher]